• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

非酒精性脂肪性肝病/非酒精性脂肪性肝炎中的生活方式改变：事实与数据。

Lifestyle modification in NAFLD/NASH: Facts and figures.

作者信息

Hallsworth Kate, Adams Leon A

机构信息

Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

Liver Unit, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, Upon Tyne, UK.

出版信息

JHEP Rep. 2019 Nov 5;1(6):468-479. doi: 10.1016/j.jhepr.2019.10.008. eCollection 2019 Dec.

DOI:10.1016/j.jhepr.2019.10.008
PMID:32039399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7005657/
Abstract

The development of non-alcoholic fatty liver disease is closely linked to lifestyle factors, namely excessive caloric intake coupled with reduced physical activity and exercise. This review aims to examine the evidence behind lifestyle change as a tool to improve hepatic steatosis and liver histology in patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. Furthermore, potential barriers to adopting lifestyle changes and strategies to overcome these barriers in the clinical setting are discussed.

摘要

非酒精性脂肪性肝病的发展与生活方式因素密切相关，即热量摄入过多，同时体力活动和锻炼减少。本综述旨在研究生活方式改变作为改善非酒精性脂肪性肝病/非酒精性脂肪性肝炎患者肝脂肪变性和肝脏组织学的一种手段背后的证据。此外，还讨论了在临床环境中采用生活方式改变的潜在障碍以及克服这些障碍的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e33f/7005657/8013bcfb3313/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e33f/7005657/14e833729a8a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e33f/7005657/d26b3567dfc9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e33f/7005657/8013bcfb3313/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e33f/7005657/14e833729a8a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e33f/7005657/d26b3567dfc9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e33f/7005657/8013bcfb3313/gr3.jpg

相似文献

1
Lifestyle modification in NAFLD/NASH: Facts and figures.非酒精性脂肪性肝病/非酒精性脂肪性肝炎中的生活方式改变：事实与数据。
JHEP Rep. 2019 Nov 5;1(6):468-479. doi: 10.1016/j.jhepr.2019.10.008. eCollection 2019 Dec.
2
Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity.非酒精性脂肪性肝病与生活方式改变，重点关注体育活动。
Korean J Intern Med. 2018 Jan;33(1):64-74. doi: 10.3904/kjim.2017.343. Epub 2017 Dec 6.
3
Treatment of NAFLD with diet, physical activity and exercise.非酒精性脂肪性肝病的饮食、身体活动和运动治疗。
J Hepatol. 2017 Oct;67(4):829-846. doi: 10.1016/j.jhep.2017.05.016. Epub 2017 May 23.
4
Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease.癌症相关基因表达与非酒精性脂肪性肝病的疾病严重程度和可改变的生活方式因素有关。
Nutrition. 2019 Jun;62:100-107. doi: 10.1016/j.nut.2018.12.001. Epub 2018 Dec 13.
5
(C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle.（C）-美沙西汀呼气试验提供了与脂肪储存相关而非与生活方式相关的亚临床肝功能障碍的证据。
JHEP Rep. 2020 Nov 4;3(1):100203. doi: 10.1016/j.jhepr.2020.100203. eCollection 2021 Feb.
6
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention.非酒精性脂肪性肝病（NAFLD）/非酒精性脂肪性肝炎（NASH）相关肝纤维化：机制、治疗与预防
Ann Transl Med. 2021 Apr;9(8):729. doi: 10.21037/atm-20-4354.
7
Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis.非酒精性脂肪性肝病和脂肪性肝炎的管理
J Clin Exp Hepatol. 2012 Jun;2(2):156-73. doi: 10.1016/S0973-6883(12)60104-2. Epub 2012 Jul 21.
8
Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need.非酒精性脂肪性肝病患者自我管理的定量评估：未满足的临床需求。
World J Gastroenterol. 2024 Jul 7;30(25):3143-3146. doi: 10.3748/wjg.v30.i25.3143.
9
Role of diet and nutritional management in non-alcoholic fatty liver disease.饮食和营养管理在非酒精性脂肪性肝病中的作用。
J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:81-7. doi: 10.1111/jgh.12244.
10
Lifestyle interventions for non-alcoholic fatty liver disease.非酒精性脂肪性肝病的生活方式干预措施。
Saudi J Biol Sci. 2019 Nov;26(7):1519-1524. doi: 10.1016/j.sjbs.2018.12.016. Epub 2019 Jan 3.

引用本文的文献

1
Barriers and facilitators to non-pharmacological management of metabolic dysfunction-associated steatotic liver disease: a qualitative evidence synthesis.代谢功能障碍相关脂肪性肝病非药物管理的障碍与促进因素：一项定性证据综合分析
Front Pharmacol. 2025 Aug 29;16:1615809. doi: 10.3389/fphar.2025.1615809. eCollection 2025.
2
Efficacy of different interventions for nonalcoholic fatty liver disease: A meta-analysis of lifestyle modifications, silymarin, and medications.不同干预措施对非酒精性脂肪性肝病的疗效：生活方式改变、水飞蓟素和药物治疗的荟萃分析
Asia Pac J Clin Nutr. 2025 Aug;34(4):516-530. doi: 10.6133/apjcn.202508_34(4).0003.
3

本文引用的文献

1
A carbohydrate-reduced high-protein diet improves HbA and liver fat content in weight stable participants with type 2 diabetes: a randomised controlled trial.低碳水化合物高蛋白饮食可改善 2 型糖尿病患者体重稳定时的 HbA 和肝脂肪含量：一项随机对照试验。
Diabetologia. 2019 Nov;62(11):2066-2078. doi: 10.1007/s00125-019-4956-4. Epub 2019 Jul 23.
2
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial.维生素 E 对 2 型糖尿病非酒精性脂肪性肝炎患者的作用：一项随机对照试验。
Diabetes Care. 2019 Aug;42(8):1481-1488. doi: 10.2337/dc19-0167. Epub 2019 May 21.
3
Risks of Light and Moderate Alcohol Use in Fatty Liver Disease: Follow-Up of Population Cohorts.
Discrete Choice Experiments and Conjoint Analyses in Health Screening Programs for Type 2 Diabetes and Liver Disease: A Scoping Review.
2型糖尿病和肝病健康筛查项目中的离散选择实验与联合分析：一项范围综述
Can Liver J. 2025 Feb 25;8(1):63-78. doi: 10.3138/canlivj-2024-0050. eCollection 2025 Feb.
4
Comparison of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Steatotic Liver Disease.二肽基肽酶-4抑制剂与钠-葡萄糖协同转运蛋白-2抑制剂在糖尿病合并脂肪性肝病患者中的疗效比较
Gut Liver. 2025 Sep 15;19(5):758-769. doi: 10.5009/gnl240616. Epub 2025 Jul 18.
5
Pharmacological inhibition of G protein-coupled receptor kinase 5 decreases high-fat diet-induced hepatic steatosis in mice.G蛋白偶联受体激酶5的药理学抑制作用可减轻高脂饮食诱导的小鼠肝脏脂肪变性。
bioRxiv. 2025 Jun 28:2025.06.25.661655. doi: 10.1101/2025.06.25.661655.
6
Dietary inflammatory index and non-alcoholic fatty liver disease risk: a systematic review and meta-analysis of observational studies.饮食炎症指数与非酒精性脂肪性肝病风险：观察性研究的系统评价与荟萃分析
Front Nutr. 2025 Jun 20;12:1596300. doi: 10.3389/fnut.2025.1596300. eCollection 2025.
7
Feasibility of a digital lifestyle intervention (VITALISE) to support weight loss in patients with MASLD in routine secondary care.在常规二级护理中，数字生活方式干预（VITALISE）对支持非酒精性脂肪性肝病（MASLD）患者减肥的可行性。
BMJ Open Gastroenterol. 2025 Jun 30;12(1):e001771. doi: 10.1136/bmjgast-2025-001771.
8
Long-term exposure to ambient air pollution and the incidence of nonalcoholic fatty liver disease: a cohort study.长期暴露于环境空气污染与非酒精性脂肪性肝病的发病率：一项队列研究。
Int J Epidemiol. 2025 Jun 11;54(4). doi: 10.1093/ije/dyaf101.
9
Fatty Liver and Hyperuricemia in Workers: Combined Effects on Metabolic Dysfunction and the Role of Lifestyle Factors.工人中的脂肪肝和高尿酸血症：对代谢功能障碍的联合影响及生活方式因素的作用
Metabolites. 2025 May 9;15(5):318. doi: 10.3390/metabo15050318.
10
Challenges and needs in the management of non-alcoholic fatty liver disease from the perspective of gastroenterology and hepatology specialists: a qualitative study.从胃肠病学和肝病学专家角度看非酒精性脂肪性肝病管理中的挑战与需求：一项定性研究
BMC Gastroenterol. 2025 May 22;25(1):396. doi: 10.1186/s12876-025-03921-z.
在脂肪肝疾病中，轻度和中度饮酒的风险：人群队列的随访。
Hepatology. 2020 Mar;71(3):835-848. doi: 10.1002/hep.30864. Epub 2019 Oct 8.
4
Exercise prescription in patients with cirrhosis: Recommendations for clinical practice.肝硬化患者的运动处方：临床实践建议
Rev Gastroenterol Mex (Engl Ed). 2019 Jul-Sep;84(3):326-343. doi: 10.1016/j.rgmx.2019.02.011. Epub 2019 Jun 28.
5
Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study.利用理论领域框架识别诊断和管理非酒精性脂肪性肝病指南实施的障碍和促进因素：一项定性研究。
Transl Behav Med. 2020 Oct 8;10(4):1016-1030. doi: 10.1093/tbm/ibz080.
6
The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content.地中海饮食比低脂饮食更有益，其有益影响可能是通过降低肝内脂肪含量来实现的。
J Hepatol. 2019 Aug;71(2):379-388. doi: 10.1016/j.jhep.2019.04.013. Epub 2019 May 8.
7
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.亚洲地区非酒精性脂肪性肝病的流行率、发病率和结局：系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2019 May;4(5):389-398. doi: 10.1016/S2468-1253(19)30039-1. Epub 2019 Mar 20.
8
Home-Based Exercise in Patients Awaiting Liver Transplantation: A Feasibility Study.居家锻炼在等待肝移植患者中的应用：一项可行性研究。
Liver Transpl. 2019 Jul;25(7):995-1006. doi: 10.1002/lt.25442. Epub 2019 Jun 6.
9
Physical Activity and Sedentary Time: Association with Metabolic Health and Liver Fat.体力活动与久坐时间：与代谢健康和肝脂肪的关系。
Med Sci Sports Exerc. 2019 Jun;51(6):1169-1177. doi: 10.1249/MSS.0000000000001901.
10
Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial.低糖饮食与常规饮食对青少年非酒精性脂肪肝的影响：一项随机临床试验。
JAMA. 2019 Jan 22;321(3):256-265. doi: 10.1001/jama.2018.20579.